Skip to content

Clinical trials

Observational Vulvar Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Phase: Observational Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20062
20082
20091
20112
20121
20131
20192
20201
20212
20223
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting3
Terminated3
Unknown status3
Active, not recruiting3
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
Gynecologic Oncology Group2
Memorial Sloan Kettering Cancer Center2
Abramson Cancer Center at Penn Medicine1
AstraZeneca1
New York Stem Cell Foundation Research Institute1
Northwestern University1
OHSU Knight Cancer Institute1
Ohio State University Comprehensive Cancer Center1
Precision Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms23
Uterine Cervical Neoplasms19
Ovarian Neoplasms13
Vaginal Neoplasms12
Endometrial Neoplasms10
Fallopian Tube Neoplasms8
Uterine Neoplasms8
Anus Neoplasms7
Breast Neoplasms6
Esophageal Neoplasms6

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.